Suppr超能文献

狼疮中自身抗体产生调节的细胞和分子机制。

Cellular and molecular mechanisms of regulation of autoantibody production in lupus.

作者信息

Hahn Bevra H, Ebling Fanny, Singh Ram R, Singh Ram P, Karpouzas George, La Cava Antonio

机构信息

Division of Rheumatology, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA 91436, USA.

出版信息

Ann N Y Acad Sci. 2005 Jun;1051:433-41. doi: 10.1196/annals.1361.085.

Abstract

The hyperactive interaction between helper T cells and autoimmune B cells in individuals predisposed to systemic lupus erythematosus (SLE) can be interrupted by induction of regulatory and suppressor T cells. Using two strategies-high dose tolerance to an immunoglobulin-derived peptide, and minigene vaccination with DNA encoding T cell epitopes presented by MHC class I molecules-our group has induced at least three types of regulatory/suppressive T cells. They include CD8+ T cells that suppress helper T cells by cytokine secretion, CD8+ T suppressors that kill B cells making anti-DNA antibodies, and peptide-binding CD4+CD25+ regulatory T cells that suppress B cells by direct cell contact. Each of these lymphocyte subsets suppresses anti-DNA antibody production and delays the onset of nephritis in BWF1 lupus-prone mice. Patients with SLE have amino acid sequences similar to those from murine anti-DNA antibodies used in these studies, and at similar locations in the VH regions of anti-DNA immunoglobulins. Therefore, strategies described here might ultimately be useful in therapy of the human disease.

摘要

在易患系统性红斑狼疮(SLE)的个体中,辅助性T细胞与自身免疫性B细胞之间的过度活跃相互作用可通过诱导调节性和抑制性T细胞来中断。利用两种策略——对免疫球蛋白衍生肽的高剂量耐受,以及用编码由MHC I类分子呈递的T细胞表位的DNA进行小基因疫苗接种——我们的研究小组已诱导出至少三种调节性/抑制性T细胞。它们包括通过细胞因子分泌抑制辅助性T细胞的CD8 + T细胞、杀死产生抗DNA抗体的B细胞的CD8 + T抑制细胞,以及通过直接细胞接触抑制B细胞的肽结合CD4 + CD25 +调节性T细胞。这些淋巴细胞亚群中的每一种都能抑制抗DNA抗体的产生,并延缓BWF1狼疮易感小鼠肾炎的发病。SLE患者具有与这些研究中所用鼠抗DNA抗体相似的氨基酸序列,且位于抗DNA免疫球蛋白VH区域的相似位置。因此,这里描述的策略最终可能对人类疾病的治疗有用。

相似文献

1
Cellular and molecular mechanisms of regulation of autoantibody production in lupus.
Ann N Y Acad Sci. 2005 Jun;1051:433-41. doi: 10.1196/annals.1361.085.
2
Manipulation of immune regulation in systemic lupus erythematosus.
Autoimmun Rev. 2005 Nov;4(8):515-9. doi: 10.1016/j.autrev.2005.04.008.
4
Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Front Immunol. 2021 May 19;12:662901. doi: 10.3389/fimmu.2021.662901. eCollection 2021.
5
Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8 and CD4 Regulatory T Cells in Lupus.
Front Immunol. 2021 Nov 19;12:718359. doi: 10.3389/fimmu.2021.718359. eCollection 2021.

引用本文的文献

2
Immunological Avalanches in Renal Immune Diseases.
Biomedicines. 2025 Apr 21;13(4):1003. doi: 10.3390/biomedicines13041003.
4
Lupus Nephritis Biomarkers: A Critical Review.
Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805.
5
Blood Composite Scores in Patients with Systemic Lupus Erythematosus.
Biomedicines. 2023 Oct 13;11(10):2782. doi: 10.3390/biomedicines11102782.
7
Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study.
Clin Immunol. 2023 Feb;247:109239. doi: 10.1016/j.clim.2023.109239. Epub 2023 Jan 20.
9
Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction.
Patient Prefer Adherence. 2018 Nov 21;12:2475-2479. doi: 10.2147/PPA.S147163. eCollection 2018.

本文引用的文献

2
Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review.
Int Immunopharmacol. 2005 Jan;5(1):7-11. doi: 10.1016/j.intimp.2004.09.003.
9
CD1d deficiency exacerbates inflammatory dermatitis in MRL-lpr/lpr mice.
Eur J Immunol. 2004 Jun;34(6):1723-32. doi: 10.1002/eji.200324099.
10
An integrated model of immunoregulation mediated by regulatory T cell subsets.
Adv Immunol. 2004;83:253-88. doi: 10.1016/S0065-2776(04)83008-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验